This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The enactment of adult-use cannabis legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions, according to data published in the journal Drug and Alcohol Dependence. Our results indicate that RML in Colorado and Washington was not associated with an increase in treatment admissions.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008. cannabis arrest data since 2008.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Substance abuse education and treatment programs. Key Findings.
Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Researchers Jeremy Mennis and Gerald J.
In the article — “Is Marijuana as Safe as We Think?” — writer Malcolm Gladwell focused on a 2017 report by the National Academy of Medicine that examined the scientific evidence of the health effects and therapeutic purposes of cannabis and cannabinoids. In 2017, for example, Washington had 304.5
Luckily, states such as Colorado, Washington, and California have had marijuana laws in place long enough for researchers to collect data and better understand the effects of legalization on behaviors such as driving under the influence. Their results may assuage some of these concerns. FACTORS INFLUENCING RESULTS. INADEQUATE TESTING.
In addition, data from the 2017 National Survey on Drug Use and Health showed a potential inverse relationship between marijuana and opioid use, based on data that reported a drop of opioid misuse from 2016 to 2017 (from 11.8 Medical cannabis is an effective and safe alternative for pain treatment. million to 11.4
Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. A literature review of existing research suggested that CBD specifically may hold therapeutic potential for the treatment of insomnia.
A recent peer-reviewed article published in the Journal of Drug Issues sought to provide quantitative data on the spillover effect , a term used to describe the influence of legalized marijuana on neighboring states. This data suggests a buffering effect of legalization on crime in neighboring areas, rather than a crime-inducing effect.
For the first time in over 50 years, a federal grant has been allocated for studying psychedelic treatment. He conducted the first blinded human research study into the psychoactive effects of salvinorin A in 2011 and published data on MDMA pill testing services in 2017. The Government Gets Involved in Psychedelics .
In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Physicians should consider these aspects when advising their patients about treatment with medicinal cannabis.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. million more on CBD products in 2021 compared to 2017 — a 413.4%
The special retail tax rate was 10% until the legislature and governor increased it in July 2017. Also, until July 2017, a 2.9% Of the cannabis-related tax revenue it collects, the state distributes 40% to public schools, 15% to law enforcement, and 25% to mental health and treatment programs. million as of April 2021.
In 2019, that trend finally appeared to shift as the FBI’s Uniform Crime Report tallied 545,601 marijuana arrests compared to 663,367 in 2018 and 659,700 in 2017. Between 2016-2018, despite rapidly expanding state legalization, there was a slight increase in marijuana-related arrests year over year. Find Out if You Qualify. Get Started.
Since 2017, anyone in the Granite State in possession of less than three-quarters of an ounce of marijuana flower or five grams or less of hash or concentrates is subject to violation and not a criminal offense. In its early days medical marijuana may have been mainly known as a treatment for glaucoma, cancer, or AIDS. New Hampshire.
CBD is additionally being investigated as an available treatment for pain, anxiety, and schizophrenic psychosis symptoms in humans. According to experts, CBD is used due to its healing properties, though there’s no conclusive data on this use. These two syndromes are two rare and severe medical specialty seizure disorders.
Validates Cepharanthine’s potential in treating various cancers with unsatisfactory treatment options. Additionally, there were several instances in which cepharanthine displayed growth inhibition which was comparable or superior to current gold standard treatments, including colorectal, liver and skin cancers.
Gresh has joined a growing number of patients who swear by medical cannabis not only as a treatment option for chronic pain, but also as a substitute for prescription opioids used in pain management. They’re an effective treatment for pain, but they’re not great for chronic pain, and many people are reluctant to start on opioids,” he said.
He said that 2017 was the first year that about half of the impairment-involved fatalities involved “drug use of some kind.” I think the data is too new,” responded Schoening. When you look at any set of data out of context it’s easy to draw conclusions that may not necessarily reflect the entire community,” she said.
In 2017, researchers performed an analysis of observational clinical studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products. Their findings included the following: “The average daily dose ranged between 1 and 50 mg/kg, with treatment length from 3 to 12 months (mean 6.2 12 September 2018.
The Relationship Between Marijuana Use and Psychosis Using the Optum Clinformatics DataMart Database , which functions as an anonymous Medicare Advantage and commercial claims database, scientists were able to gather data with unprecedented precision. How Several Sources of Data Were Used in the Research In 2019, an estimated 48.2
Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. 1, 2017, following a 2016 ballot measure. Dr. Dawn Boothe is a professor of veterinary physiology and pharmacology at Auburn University studying cannabis’s potential as a veterinary treatment.
At the same time, the bill would redirect tax revenue from a legal industry towards various programs that redress harms from the War on Drugs, while also increasing and improving public education and treatment programs geared towards responsible use, reducing overdoses, and saving lives. times more likely. times more likely.
Data from the National Institute of Health indicates that younger women are more likely to use marijuana during pregnancy, with urine toxicology testing showing that 19% of pregnant women aged 18-25 screened positive for marijuana use. These numbers reflect both non-medical and medicinal marijuana use.
Charlotte’s Web took the unusual step of issuing a public response to the refusals, available here , with a link to the company’s also public letter to the FDA here , which responds directly to the agency’s criticisms of the data provided and alleging factual inaccuracies in its response. Still About Safety. A Legislative Fix? .
The collection of data for the final study was through focused interviews with a snowball sample of eight participants who have experienced trying to enter the cannabis industry in Western City, California. Data were analyzed based on the central question, and three themes emerged. SSRN: [link] or [link] McVey, E (2017).
Yet, data suggests otherwise. And according to that data, there appears to be little to no correlation between cannabis legalization and underage marijuana use on a state-by-state basis. decline in youth marijuana use from 2015 to 2017. Yet, once again, the data shows that this simply isn’t the case. California.
Novel therapies and psychedelic treatments are rapidly gaining popularity across large swathes of North America as the awareness of mental health disorders and the revolutionary effects of psychedelics in their treatment become more mainstream. Change is always hard, and the finance world is witness to this. for the SPY.
In 2017, researchers performed an analysis of observational studies on the treatment of refractory epilepsy with cannabidiol (CBD)-based products and reported on the side effects of the CBD products: “The reports of mild (158/216, 76% vs. 148/447, 33%, p. Pamplona F, da Silva L and Coan A. 12 September 2018. See the Answer.
Kicking any addiction requires discipline, patience and a willingness to follow a treatment plan — something that doesn’t come easily to many young people, experts said. with 1 in 4 high school students reportedly using the products, according to federal data. The state’s underage vaping rate is the highest in the U.S.,
Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The popularity of medical cannabinoids (MCs) treatment is growing, as more countries enable MCs treatment for various indications in adults 1. Metrics details. Introduction. Search strategy.
According to an interesting and for some eye-opening new study published in the journal Drug and Alcohol Dependence, the enactment of marijuana legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions.
But it doesn’t take a seismologist to know the Big One(s) are right around the corner for the Cannabis industry, who should have noticed last week as an established cruise line company looked to consummate a $76 Million TCPA settlement from 2017, only to have the Plaintiffs’ counsel ask the court to bump its initial $15 million fee by another $3.49
The findings suggest that some ADHD patients may consume cannabis as a “substitute treatment” for more conventional medications, authors concluded. METHODS: Participants were adult patients licensed for medical cannabis (MC) treatment who also reported a diagnosis of ADHD by a physician.
After months of development, my partner and I built and successfully launched the beta for our cannabis data-analytics software, Jade Insights. It’s a software platform that helps cannabis businesses augment their process by providing insights for data-backed decision-making. ” JOHN KAGIA. ” OPHELIA CHONG.
in 2002 to 7% in 2017. The meta-analysis reviewed 32 studies containing data from approximately 5.5 Other research has found that children with neurodevelopmental and neuropsychiatric disorders may even benefit from treatment with exogenous cannabinoids such as CBD. An estimated 4.2% in certain states such as Maine.
Drugs used for the treatment of HIV and AIDS are called antiretroviral medications, and there are several different classes of these drugs: Fusion/Entry Inhibitors (they prevent, or more precisely slow down HIV from entering healthy cells). How classical pharmaceuticals fight HIV. They also reported an overall increase in pleasure. (
Charlotte’s Web took the unusual step of issuing a public response to the refusals, available here , with a link to the company’s also public letter to the FDA here , which responds directly to the agency’s criticisms of the data provided and alleging factual inaccuracies in its response. Still About Safety. A Legislative Fix? .
Charlotte’s Web took the unusual step of issuing a public response to the refusals, available here , with a link to the company’s also public letter to the FDA here , which responds directly to the agency’s criticisms of the data provided and alleging factual inaccuracies in its response. Still About Safety.
Some studies suggest those using opioid medications can even reduce or eliminate their dependence on these substances by introducing medical marijuana to their treatment plans. In 2017, the number of medical cannabis patients in Canada topped 200,000 for the first time. The Opioid Crisis Claimed 4,000 Lives in 2017.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1). BMC Fam Pract.
Below are recommendations mostly based on extrapolated animal data and studies on essential oils from plants. 18 19 Limonene epoxide, a limonene derivative, was identified as a “new approach for the treatment of anxiety” in a 2012 preclinical trial. In other words, this is a starting point but it’s far from definitive.
While there’s substantial human research that pharmaceutical combinations of CBD and THC can reduce pain, at the present time there’s much less data on CBD or CBD-dominant hemp products used alone for pain, but there are several small studies that suggest effectiveness, often at higher doses, according to Dr. Sulak.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content